Conditions: Alzheimer's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 72
Healthy volunteers: no

Brief summary:
The purpose of this pilot study is to evaluate the potential effects of soy isoflavone supplements on cognitive function for men and women with Alzheimer's Disease (AD). Preliminary studies evaluating the effects of soy supplements on memory in cognitively healthy older adults have yielded promising results that are now being evaluated in patients with AD. It is hypothesized that isoflavone supplements will ameliorate cognitive declines for older adults diagnosed with Alzheimer's disease, when compared to subjects on placebo.

Detailed description:

Arms:
arm 1: 100mg/day soy isoflavones arm 2: 100mg/day matching placebo

Interventions: intervention 1: Novasoy intervention 2: Placebo
Intervention descriptions: intervention 1: 100mg/day soy isoflavones intervention 2: 100mg/day matching placebo

Protocol document: